Autologous adipose tissue injection versus platelet-rich plasma (PRP) injection in the treatment of knee osteoarthritis: a randomized, controlled study – study protocol
Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage h...
Saved in:
Published in | BMC musculoskeletal disorders Vol. 21; no. 1; pp. 314 - 8 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
20.05.2020
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1471-2474 1471-2474 |
DOI | 10.1186/s12891-020-03345-8 |
Cover
Abstract | Background
Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods.
Methods
This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction.
Discussion
This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias.
Trial registration
name of registry:
ClinicalTrials.gov
, trial registration number:
NCT04321629
, retrospectively registered on date of registration. |
---|---|
AbstractList | Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods.BACKGROUNDKnee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods.This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction.METHODSThis is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction.This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias.DISCUSSIONThis study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias.name of registry: ClinicalTrials.gov, trial registration number: NCT04321629, retrospectively registered on date of registration.TRIAL REGISTRATIONname of registry: ClinicalTrials.gov, trial registration number: NCT04321629, retrospectively registered on date of registration. Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods. Methods This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction. Discussion This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias. Trial registration name of registry: ClinicalTrials.gov, trial registration number: NCT04321629, retrospectively registered on date of registration. Keywords: Autologous subcutaneous adipose tissue, Platelet rich plasma, Knee OA, Intra- articular injection Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods. Methods This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction. Discussion This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias. Trial registration name of registry: ClinicalTrials.gov , trial registration number: NCT04321629 , retrospectively registered on date of registration. Abstract Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods. Methods This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction. Discussion This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias. Trial registration name of registry: ClinicalTrials.gov , trial registration number: NCT04321629 , retrospectively registered on date of registration. Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods. Methods This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction. Discussion This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias. Trial registration name of registry: ClinicalTrials.gov, trial registration number: NCT04321629, retrospectively registered on date of registration. Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods. This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction. This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias. Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability and social isolation. OA is a huge economic burden for the patient and a large strain for the whole healthcare system. Articular cartilage has a small potential to repair, with progressively more clinicians emphasizing cellular therapy. Subcutaneous fat tissue in human body is a large reservoir of mesenchymal stem cells (MSCs) and is been harvested in minimally invasive, simple procedure. Up to date there is no prospective randomized controlled studies demonstrating effectiveness and role of adipose tissue injections in OA treatment. The purpose of this study is to assess functional and clinical changes among patients with symptomatic knee OA treated with intra-articular injections of autologous adipose tissue or platelet rich plasma (PRP) and to compare efficacy of both therapeutic methods. This is a prospective, randomized, controlled study. Patients who meet inclusion criteria will be allocated to Fat Tissue group or PRP group randomly. Subjects will receive an intra articular injection with autologous adipose tissue and PRP respectively. Patients will be assessed five times: before treatment and 1, 3, 6 and 12 months after the treatment. The assessment consists of patient reported outcome measures (The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee 2000, the Western Ontario and McMaster Universities Osteoarthritis Index, the Health Questionnaire EQ- 5D- 5 L), three functional tests (The Timed Up and Go Test, The 5 Times Sit to Stand Test, The 10 m Walk Test) and Maximal Isometric Voluntary Contraction. This study protocol has several strengths and weaknesses. One of strongest point of this study is the wide, multidimensional functional assessment which will give a large amount of objective data. On the other hand, lack of blinding has to be considered as a risk of both subject and investigator bias. name of registry: ClinicalTrials.gov, trial registration number: NCT04321629, retrospectively registered on date of registration. |
ArticleNumber | 314 |
Audience | Academic |
Author | Kaszyński, Jakub Piontek, Tomasz Bąkowski, Paweł Wałecka, Joanna Ciemniewska-Gorzela, Kinga Bąkowska-Żywicka, Kamilla |
Author_xml | – sequence: 1 givenname: Paweł orcidid: 0000-0001-8661-7754 surname: Bąkowski fullname: Bąkowski, Paweł email: pawel.bakowski@rehasport.pl organization: Department of Orthopedic Surgery, Rehasport Clinic – sequence: 2 givenname: Jakub surname: Kaszyński fullname: Kaszyński, Jakub organization: Department of Orthopedic Surgery, Rehasport Clinic – sequence: 3 givenname: Joanna surname: Wałecka fullname: Wałecka, Joanna organization: Department of Orthopedic Surgery, Rehasport Clinic – sequence: 4 givenname: Kinga surname: Ciemniewska-Gorzela fullname: Ciemniewska-Gorzela, Kinga organization: Department of Orthopedic Surgery, Rehasport Clinic – sequence: 5 givenname: Kamilla surname: Bąkowska-Żywicka fullname: Bąkowska-Żywicka, Kamilla organization: Institute of Bioorganic Chemistry Polish Academy of Sciences – sequence: 6 givenname: Tomasz surname: Piontek fullname: Piontek, Tomasz organization: Department of Orthopedic Surgery, Rehasport Clinic, Department of Spine Disorders and Pediatric Orthopedics, University of Medical Sciences Poznan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32434498$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kstu1DAUhiNURC_wAiyQJTZFIsW3iR0WSKOKS6VKVAjWluOczHhI7MF2KpUV78Bb8Fg8CZ7OMMxUqMoijv39_8k5_o-LA-cdFMVTgs8IkdWrSKisSYkpLjFjfFLKB8UR4YKUlAt-sLM-LI5jXGBMhGT1o-KQUc44r-VR8Ws6Jt_7mR8j0q1d-ggo2RhHQNYtwCTrHbqGEPP5stcJekhlsGa--oqDRqdXn65e7LDWoTTPHgF0GsAl5Dv01QEgHxN4HdI82FzgNdIoaNf6wX6H9iUy3qXg-x5aFNPY3qDfP35uVsvgkze-f1w87HQf4cnmfVJ8eff28_mH8vLj-4vz6WVpKsFSqU3NG1KL1kjRsFZ33EhJeIe5npCqqQ1IYQTpRAeEUEKBUsMoqSddQ0TLMDspLta-rdcLtQx20OFGeW3V7YYPM5XbsKYHNdEYhJFV14DhtJLSMFY1QoLklGBaZa83a6_l2AzQmjyQoPs90_0TZ-dq5q-VoBzXdZ0NTjcGwX8bISY12Gig77WDfGcqY5N891LwjD6_gy78GFweVaYIryRjGd1SM50bsK7zua5ZmappRQWvKlKTTJ39h8pPC4PNdwWdzft7gme7jW47_Ju0DNA1YIKPMUC3RQhWqzirdZxVjrO6jbNaieQdkbFJr3KWf8f290vZWhpzHTeD8G8a96j-AEdtDEo |
CitedBy_id | crossref_primary_10_1016_j_msksp_2024_102983 crossref_primary_10_1186_s13018_021_02851_2 crossref_primary_10_3390_biomedicines10102527 crossref_primary_10_1016_j_bonr_2022_101601 crossref_primary_10_1186_s13018_020_01991_1 crossref_primary_10_3390_biomedicines10030684 crossref_primary_10_1177_23259671231155950 crossref_primary_10_1292_jvms_20_0730 crossref_primary_10_1007_s00402_021_03979_w |
Cites_doi | 10.1177/0363546512471299 10.1007/s11926-017-0652-x 10.1002/sctm.18-0122 10.5114/aoms.2015.52126 10.1016/j.joca.2006.05.008 10.1016/j.arth.2018.12.001 10.1111/1756-185X.13139 10.3727/096368912X657855 10.1016/j.semarthrit.2013.07.003 10.1136/bmjopen-2014-006947 10.5966/sctm.2015-0245 10.1093/asj/sjv135 10.2174/1573397113666170829155149 10.1016/j.arthro.2015.08.005 10.1016/j.arthro.2016.09.024 10.1007/s00264-018-4182-6 10.1016/j.joca.2013.07.017 10.1016/j.jvir.2017.08.004 10.1007/BF03325265 10.1111/1756-185X.13233 10.1007/s11136-011-9903-x 10.1002/14651858.CD005523.pub3 10.1177/0363546517716641 10.2519/jospt.2008.2657 10.1053/joca.2002.0807 10.1016/j.stem.2011.06.008 10.1016/j.imlet.2015.06.005 10.5966/sctm.2016-0023 10.1016/j.joca.2015.08.009 10.1016/j.stem.2008.08.008 10.1093/rheumatology/38.9.870 10.1089/ten.TEA.2012.0225 10.1016/j.gaitpost.2016.12.005 10.1186/1477-7525-1-64 10.1186/1477-7525-11-107 10.1016/j.arthro.2015.09.010 10.1186/s13075-018-1621-0 10.1186/1471-2474-14-337 10.1186/s12891-018-2105-8 10.1016/j.arthro.2018.01.048 10.1186/1477-7525-1-17 10.1002/jgm.3002 10.1093/rheumatology/kem234 10.1016/j.semarthrit.2017.03.007 10.1177/0363546516665809 10.1177/0363546505280214 |
ContentType | Journal Article |
Copyright | The Author(s) 2020 COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2020 – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7RV 7TK 7TS 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12891-020-03345-8 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts ProQuest Nursing & Allied Health Database Neurosciences Abstracts Physical Education Index ProQuest Health & Medical Complete ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection ProQuest Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Physical Education Index ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals - Free url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Physical Therapy |
EISSN | 1471-2474 |
EndPage | 8 |
ExternalDocumentID | oai_doaj_org_article_5a0e7c86fbec42688c336b78e8421026 PMC7240999 A627466191 32434498 10_1186_s12891_020_03345_8 |
Genre | Clinical Trial Protocol Journal Article |
GeographicLocations | Poland |
GeographicLocations_xml | – name: Poland |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7RV 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E NAPCQ O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 7QP 7TK 7TS 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c673t-ac94b197dc87b3daf4c8814f04a516b9ce87c71f7fe11212e22c32195fb17d303 |
IEDL.DBID | 7X7 |
ISSN | 1471-2474 |
IngestDate | Wed Aug 27 01:05:08 EDT 2025 Thu Aug 21 18:06:05 EDT 2025 Thu Sep 04 17:50:55 EDT 2025 Fri Jul 25 04:05:16 EDT 2025 Tue Jun 17 21:29:51 EDT 2025 Tue Jun 10 20:49:53 EDT 2025 Mon Jul 21 06:06:40 EDT 2025 Thu Apr 24 22:51:54 EDT 2025 Tue Jul 01 01:09:01 EDT 2025 Sat Sep 06 07:22:16 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Platelet rich plasma Knee OA Autologous subcutaneous adipose tissue Intra- articular injection |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c673t-ac94b197dc87b3daf4c8814f04a516b9ce87c71f7fe11212e22c32195fb17d303 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Undefined-1 content type line 23 |
ORCID | 0000-0001-8661-7754 |
OpenAccessLink | https://www.proquest.com/docview/2414683353?pq-origsite=%requestingapplication% |
PMID | 32434498 |
PQID | 2414683353 |
PQPubID | 44767 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5a0e7c86fbec42688c336b78e8421026 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7240999 proquest_miscellaneous_2405334874 proquest_journals_2414683353 gale_infotracmisc_A627466191 gale_infotracacademiconefile_A627466191 pubmed_primary_32434498 crossref_primary_10_1186_s12891_020_03345_8 crossref_citationtrail_10_1186_s12891_020_03345_8 springer_journals_10_1186_s12891_020_03345_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-05-20 |
PublicationDateYYYYMMDD | 2020-05-20 |
PublicationDate_xml | – month: 05 year: 2020 text: 2020-05-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | BMC musculoskeletal disorders |
PublicationTitleAbbrev | BMC Musculoskelet Disord |
PublicationTitleAlternate | BMC Musculoskelet Disord |
PublicationYear | 2020 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | PB Fodor (3345_CR48) 2016; 36 N Bellamy (3345_CR22) 1997; 24 EM Roos (3345_CR45) 2003; 1 PD Nguyen (3345_CR41) 2017; 6 W Hermann (3345_CR2) 2018; 14 CH Jo (3345_CR50) 2017; 45 Y Zhu (3345_CR30) 2013; 21 J Pintat (3345_CR46) 2017; 28 AI Caplan (3345_CR37) 2011; 9 RC Pereira (3345_CR33) 2013; 19 Ewa M Roos (3345_CR28) 2003; 1 J Pak (3345_CR47) 2013; 14 KL Bennell (3345_CR31) 2017; 19 WL Dai (3345_CR10) 2017; 33 AI Caplan (3345_CR38) 2008; 3 3345_CR29 D Garay-Mendoza (3345_CR13) 2018; 21 Dominik Golicki (3345_CR23) 2017; 1 Duško Spasovski (3345_CR49) 2018; 20 A Fearon (3345_CR27) 2017; 52 JE Brazier (3345_CR52) 1999; 38 AD Woolf (3345_CR4) 2003; 81 AF Anderson (3345_CR19) 2006; 34 J Chahla (3345_CR1) 2018; 34 PT Paradowski (3345_CR18) 2013; 11 S Patel (3345_CR12) 2013; 41 D Xing (3345_CR11) 2017; 20 R Theiler (3345_CR21) 2002; 10 PT Paradowski (3345_CR17) 2015; 5 C Bartholdy (3345_CR6) 2017; 47 TS Yeung (3345_CR25) 2008; 38 T Piontek (3345_CR20) 2012; 77 YG Koh (3345_CR40) 2016; 32 YS Kim (3345_CR43) 2016; 24 EM Roos (3345_CR16) 2003; 1 RE Delanois (3345_CR8) 2019; 34 M Herdman (3345_CR24) 2011; 20 EM Bartels (3345_CR7) 2016; 3 A Schiavone Panni (3345_CR15) 2019; 43 3345_CR3 A Goldberg (3345_CR26) 2012; 24 M Hiligsmann (3345_CR5) 2013; 43 WS Lee (3345_CR51) 2019; 8 YM Pers (3345_CR42) 2016; 5 F Bianchi (3345_CR14) 2013; 22 E Anitua (3345_CR35) 2007; 46 AI Caplan (3345_CR39) 2015; 168 CJ Meheux (3345_CR9) 2016; 32 Y Di (3345_CR36) 2018; 20 BJ Cole (3345_CR34) 2017; 45 K Akeda (3345_CR32) 2006; 14 G Cattaneo (3345_CR44) 2018; 19 |
References_xml | – volume: 41 start-page: 356 issue: 2 year: 2013 ident: 3345_CR12 publication-title: Am J Sports Med doi: 10.1177/0363546512471299 – volume: 19 start-page: 24 issue: 5 year: 2017 ident: 3345_CR31 publication-title: Curr Rheumatol Rep doi: 10.1007/s11926-017-0652-x – volume: 8 start-page: 504 issue: 6 year: 2019 ident: 3345_CR51 publication-title: Stem Cells Transl Med doi: 10.1002/sctm.18-0122 – volume: 1 start-page: 191 year: 2017 ident: 3345_CR23 publication-title: Archives of Medical Science doi: 10.5114/aoms.2015.52126 – volume: 14 start-page: 1272 issue: 12 year: 2006 ident: 3345_CR32 publication-title: Osteoarthr Cartil doi: 10.1016/j.joca.2006.05.008 – volume: 34 start-page: 801 issue: 4 year: 2019 ident: 3345_CR8 publication-title: J Arthroplast doi: 10.1016/j.arth.2018.12.001 – volume: 21 start-page: 140 issue: 1 year: 2018 ident: 3345_CR13 publication-title: Int J Rheum Dis doi: 10.1111/1756-185X.13139 – volume: 22 start-page: 2063 issue: 11 year: 2013 ident: 3345_CR14 publication-title: Cell Transplant doi: 10.3727/096368912X657855 – volume: 43 start-page: 303 issue: 3 year: 2013 ident: 3345_CR5 publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2013.07.003 – volume: 5 start-page: e006947 issue: 7 year: 2015 ident: 3345_CR17 publication-title: BMJ Open doi: 10.1136/bmjopen-2014-006947 – volume: 5 start-page: 847 issue: 7 year: 2016 ident: 3345_CR42 publication-title: Stem Cells Transl Med doi: 10.5966/sctm.2015-0245 – volume: 36 start-page: 229 issue: 2 year: 2016 ident: 3345_CR48 publication-title: Aesthet Surg J doi: 10.1093/asj/sjv135 – volume: 14 start-page: 108 issue: 2 year: 2018 ident: 3345_CR2 publication-title: Curr Rheumatol Rev doi: 10.2174/1573397113666170829155149 – volume: 32 start-page: 495 issue: 3 year: 2016 ident: 3345_CR9 publication-title: Arthroscopy doi: 10.1016/j.arthro.2015.08.005 – volume: 33 start-page: 659 issue: 3 year: 2017 ident: 3345_CR10 publication-title: Arthroscopy doi: 10.1016/j.arthro.2016.09.024 – volume: 43 start-page: 7 issue: 1 year: 2019 ident: 3345_CR15 publication-title: Int Orthop doi: 10.1007/s00264-018-4182-6 – volume: 21 start-page: 1627 issue: 11 year: 2013 ident: 3345_CR30 publication-title: Osteoarthr Cartil doi: 10.1016/j.joca.2013.07.017 – volume: 28 start-page: 1708 issue: 12 year: 2017 ident: 3345_CR46 publication-title: J Vasc Interv Radiol doi: 10.1016/j.jvir.2017.08.004 – volume: 81 start-page: 646 issue: 9 year: 2003 ident: 3345_CR4 publication-title: Bull World Health Organ – volume: 24 start-page: 339 issue: 4 year: 2012 ident: 3345_CR26 publication-title: Aging Clin Exp Res doi: 10.1007/BF03325265 – volume: 20 start-page: 1612 issue: 11 year: 2017 ident: 3345_CR11 publication-title: Int J Rheum Dis doi: 10.1111/1756-185X.13233 – volume: 77 start-page: 115 year: 2012 ident: 3345_CR20 publication-title: Pol Orthop Traumatol – volume: 20 start-page: 1727 issue: 10 year: 2011 ident: 3345_CR24 publication-title: Qual Life Res doi: 10.1007/s11136-011-9903-x – volume: 3 start-page: CD005523 year: 2016 ident: 3345_CR7 publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD005523.pub3 – volume: 45 start-page: 2774 issue: 12 year: 2017 ident: 3345_CR50 publication-title: Am J Sports Med doi: 10.1177/0363546517716641 – volume: 38 start-page: 410 issue: 7 year: 2008 ident: 3345_CR25 publication-title: J Orthop Sports Phys Ther doi: 10.2519/jospt.2008.2657 – volume: 10 start-page: 479 issue: 6 year: 2002 ident: 3345_CR21 publication-title: Osteoarthr Cartil doi: 10.1053/joca.2002.0807 – volume: 9 start-page: 11 issue: 1 year: 2011 ident: 3345_CR37 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2011.06.008 – volume: 168 start-page: 136 issue: 2 year: 2015 ident: 3345_CR39 publication-title: Immunol Lett doi: 10.1016/j.imlet.2015.06.005 – volume: 6 start-page: 187 issue: 1 year: 2017 ident: 3345_CR41 publication-title: Stem Cells Transl Med doi: 10.5966/sctm.2016-0023 – volume: 24 start-page: 237 issue: 2 year: 2016 ident: 3345_CR43 publication-title: Osteoarthr Cartil doi: 10.1016/j.joca.2015.08.009 – volume: 3 start-page: 229 issue: 3 year: 2008 ident: 3345_CR38 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2008.08.008 – volume: 38 start-page: 870 issue: 9 year: 1999 ident: 3345_CR52 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/38.9.870 – volume: 19 start-page: 1476 issue: 11–12 year: 2013 ident: 3345_CR33 publication-title: Tissue Eng Part A doi: 10.1089/ten.TEA.2012.0225 – ident: 3345_CR3 – ident: 3345_CR29 – volume: 52 start-page: 237 year: 2017 ident: 3345_CR27 publication-title: Gait Posture doi: 10.1016/j.gaitpost.2016.12.005 – volume: 1 start-page: 64 issue: 1 year: 2003 ident: 3345_CR28 publication-title: Health and Quality of Life Outcomes doi: 10.1186/1477-7525-1-64 – volume: 24 start-page: 2413 issue: 12 year: 1997 ident: 3345_CR22 publication-title: J Rheumatol – volume: 1 start-page: 64 year: 2003 ident: 3345_CR16 publication-title: Health Qual Life Outcomes doi: 10.1186/1477-7525-1-64 – volume: 11 start-page: 107 year: 2013 ident: 3345_CR18 publication-title: Health Qual Life Outcomes doi: 10.1186/1477-7525-11-107 – volume: 32 start-page: 97 issue: 1 year: 2016 ident: 3345_CR40 publication-title: Arthroscopy. doi: 10.1016/j.arthro.2015.09.010 – volume: 20 start-page: 128 issue: 1 year: 2018 ident: 3345_CR36 publication-title: Arthritis Res Ther doi: 10.1186/s13075-018-1621-0 – volume: 14 start-page: 337 year: 2013 ident: 3345_CR47 publication-title: BMC Musculoskelet Disord doi: 10.1186/1471-2474-14-337 – volume: 19 start-page: 176 issue: 1 year: 2018 ident: 3345_CR44 publication-title: BMC Musculoskelet Disord doi: 10.1186/s12891-018-2105-8 – volume: 34 start-page: 1719 issue: 5 year: 2018 ident: 3345_CR1 publication-title: Arthroscopy. doi: 10.1016/j.arthro.2018.01.048 – volume: 1 start-page: 17 year: 2003 ident: 3345_CR45 publication-title: Health Qual Life Outcomes doi: 10.1186/1477-7525-1-17 – volume: 20 start-page: e3002 issue: 1 year: 2018 ident: 3345_CR49 publication-title: The Journal of Gene Medicine doi: 10.1002/jgm.3002 – volume: 46 start-page: 1769 issue: 12 year: 2007 ident: 3345_CR35 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kem234 – volume: 47 start-page: 9 issue: 1 year: 2017 ident: 3345_CR6 publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2017.03.007 – volume: 45 start-page: 339 issue: 2 year: 2017 ident: 3345_CR34 publication-title: Am J Sports Med doi: 10.1177/0363546516665809 – volume: 34 start-page: 128 issue: 1 year: 2006 ident: 3345_CR19 publication-title: Am J Sports Med doi: 10.1177/0363546505280214 |
SSID | ssj0017839 |
Score | 2.3225408 |
Snippet | Background
Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability... Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability and social... Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients' quality of life and may cause disability... Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause disability... Abstract Background Knee osteoarthritis (OA) is a common, chronic, progressive and degenerative disease which affects patients’ quality of life and may cause... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 314 |
SubjectTerms | Adipose tissue Adipose Tissue - transplantation Arthritis Autografts Autologous subcutaneous adipose tissue Body fat Bone surgery Care and treatment Cartilage Cartilage (articular) Cartilage diseases Clinical Trials, Phase II as Topic Contraction Disease Epidemiology Exercise Humans Injection Injections, Intra-Articular Internal Medicine Intra- articular injection Isometric Joint surgery Knee Knee OA Manipulative therapy Medical research Medicine Medicine & Public Health Mesenchyme Orthopedics Orthopedics and biomechanics Osteoarthritis Osteoarthritis, Knee - therapy Pain Pain Measurement Patient Reported Outcome Measures Patients Physical therapy Platelet rich plasma Platelet-Rich Plasma - metabolism Platelets Prospective Studies Quality of Life Questionnaires Randomized Controlled Trials as Topic Rehabilitation Rheumatology Social interactions Sports Medicine Stem cell transplantation Stem cells Study Protocol Treatment Outcome |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LjtMwFLXQrNggYHgEBmQkxENMNHHtxA67ghiNkEAjxEizs_xUA61T0c5iZsU_8Bd8Fl_CtZOUZhCwYdfUN6kfx_fR3HuM0GNdGYi5vI0bqc6ZdzRXunR5WWtutHC8TkVi795XRyfs7Wl5unXUV8wJ6-iBu4k7KFXhuBGVhx8DayKEobTSXDjBYrSSyLaLuhiCqf79AQe7P5TIiOpgBVo4ZvhAqFRQyspcjMxQYuv_XSdvGaXLCZOX3pomY3R4HV3rvUg87Xp_A11x4SbanQaIoBfn-AlOeZ3pD_Nd9H16ls6ohRAfK9ss25XD6zTduAmfUiZWwDE5A9qXc3A9YSVz0I6zeLVaKPzs-MPx8y3ZJmDwGvEmRR23Hn8OzuFYL9LCjM4SUdJLrDAYQtsumgtn93GfFD93FidOW_zj67f-UySLaAGRt9DJ4ZuPr4_y_oSG3FScrnNlaqZJza0RXFOrPDNCEOYLpkpS6do4wQ0nnnsHfh2ZuMnEUNCRpdeEW7Cet9FOaIO7izAjlnhjwd3QhjFTaKogmCIGMEQjaDJEhgWTpqcvj6dozGUKY0Qlu0WWsMgyLbIUGXqxuWfZkXf8VfpVxMFGMhJvpy8AjrKHo_wXHDP0NKJIRvUA3TOqr3KAQUaiLTmNZx2BT1STDO2NJGFbm3HzgEPZq5WVBHeLVbFMjmbo0aY53hlT5YIDJIFMV17NWYbudLDdDAm8Z8pYDUPlI0CPxjxuCc0skY5zeC4EExnaH6D_q1t_ntN7_2NO76Ork7R1S9Dpe2hn_eXMPQBXcK0fpl3_E1GeXI0 priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFD4a44UXLhuXwEBGQlzEMuraiR0khApimpBAFVqlvVmx49BCm5ReJMYT_4F_wc_il3DsXLaMsbemtqM45zu3-FwAHunYoM-VZ46RkpDnloWpjmwYJVoYLa1IfJLYh4_xwYi_P4qONqBpd1S_wOW5rp3rJzVaTPe-fzt-jQz_yjO8jF8sUca6-B10hHqM8SiUl-CyPy9yoXz85FRBoDXQJM6cu66jnHwN_38l9SlVdTaM8sxZqldR-9fham1bkkEFhhuwYYst2B4U6FfPjslj4qM9_Wf0Lbg2rAlEDqu6Atvwe7D2zWzL9ZKk2WReLi1ZebqQSfHFh2wVxEVx4Ph8ijYqkjxEMTp2V8tZSp4OPw2fnZo7KQial6SNZSdlTr4W1hKXWFIiZse-otJLkhLUmFk5m_yw2S6po-enNiO--C358_NX_ctVlSgRujdhtP_u8O1BWLdyCE0s2CpMTcI1TURmpNAsS3NupKQ87_E0orFOjJXCCJqL3KIBSPu23zcMhWmUayoyVLO3YLMoC3sHCKcZzU2Gdok2nJueZil6XdQg2JhDVwC0oaEydZ1z125jqry_I2NV0V0h3ZWnu5IBPG_XzKsqHxfOfuOg0c50Fbr9H-Xis6oZXkVpzwoj4xyZBK0gKQ1jsRbSSu687DiAJw5YyiEbH8-kdToEbtJV5FID1xQJjaeEBrDTmYn8b7rDDTRVwz4K0c9jl0_HAnjYDruVLqausIgknFPlYQsewO0Kye2W0MxmnCe4VdHBeGfP3ZFiMvbVyQXeF72OAHYbbjh5rP-_07sX7-IeXOl7Po1QrO_A5mqxtvfRGlzpB57F_wLBdF4k priority: 102 providerName: Scholars Portal – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLZgSIgXBBuXjIGMhLiIRatrx3Z4KxXThDQ0ISbtzYodWy20TrV2D_DEf-Bf8LP4JRw7bmjGReKtqY-jOOc7t_icY4SeaG4g5nJ1EKQyZ87SvNKFzYtSC6OlFWUsEjt-x49O2duz4iy1yQm1MJv790TygyXoz5CbA0HOgFJW5PIqulaA4g1oHvNxt2MgwNKvi2L-OK9neGJ__t-18IYZupwieWmfNJqfw1voZvIb8ahl9G10xfpttDPyEDPPP-OnOGZyxk_k2-j6cdow30HfRxfxgFqI73FVTxfN0uJVfNd46j_GNCyPQ2YGjC9m4HcCG3NQjZNwtZxX-PnJ-5MXG7RTj8FlxF1-Om4c_uStxaFYpAEcTmKXpFe4wmAF62Y-_WLrfZwy4me2xrGhLf7x9Vv6FTpFNADHO-j08M2H8VGejmfIDRd0lVemZJqUojZSaFpXjhkpCXMDVhWE69JYKYwgTjgLTh0Z2uHQUFCQhdNE1GA676It33h7H2FGauJMDb6GNoyZgaYVRFLEAIBoQEyGyJp3yqTe5eEIjZmKMYzkquW3An6ryG8lM_Sym7NoO3f8k_p1gERHGbpuxz8AjCoJsSqqgRVGcgfAB89GSkMp10JayULkzDP0LABKBd0Aj2eqVOIAiwxdttQoHHQEDlFJMrTXowSZNv3hNSRV0ilLBb4W46FGjmbocTccZoY8OW8BSUDT1lYLlqF7LYK7JYHrTBkrYamih-3emvsjfjqJHccF3BciiQztr6Xg12P9_Z3u_h_5A3RjGOW1ANW9h7ZW5xf2IXh8K_0oivpPCtBQtQ priority: 102 providerName: Springer Nature |
Title | Autologous adipose tissue injection versus platelet-rich plasma (PRP) injection in the treatment of knee osteoarthritis: a randomized, controlled study – study protocol |
URI | https://link.springer.com/article/10.1186/s12891-020-03345-8 https://www.ncbi.nlm.nih.gov/pubmed/32434498 https://www.proquest.com/docview/2414683353 https://www.proquest.com/docview/2405334874 https://pubmed.ncbi.nlm.nih.gov/PMC7240999 https://doaj.org/article/5a0e7c86fbec42688c336b78e8421026 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3bbtMw1ILthRcuG7DAqIyEuIhFq2sndnhBWbVpqrSpGqvUNyt2HFpok7J2D_DEP_AXfBZfwrHjZssQe0nb-KTN6bk754LQKxVriLmK3ApSErLC0DBTkQmjRHGthOGJKxI7OY2PR2wwjsZ-w23p0yrXOtEp6rzSdo98HywNi22FEP24-BbaqVH26aofoXEXbcJPUTu6gY-bgItwsP7rQhkR7y9BF9s8HwiYupSyKBQtY-R69v-rma-ZpptpkzeenTqTdPQQ3fe-JE5r4j9Cd0y5hbbTEuLo-Xf8GrvsTrdtvoUeDD1B8HndR2Ab_U4v3fBaiP1xlk8X1dLglaMDnpZfXIpWiW3WBqwvZuCTAolDUJsT-2k5z_Db4dnw3TXYaYnBncRN7jquCvy1NAbbQpIKeHTiOih9wBkGC5lX8-kPk-9hny0_Mzl2zW7xn5-__DvbRaICVn2MRkeH5_3j0I9uCHXM6SrMdMIUSXiuBVc0zwqmhSCs6LIsIrFKtBFcc1LwwoDDR3qm19MUlGdUKMJzMKtP0EZZlWYHYUZyUugc_BClGdNdRTOIsogG5qKWmwJE1jSU2vc1t-M1ZtLFNyKWNd0l0F06uksRoPfNNYu6q8et0AeWNRpI25HbnaguPksv4DLKuoZrERcgFOD1CKEpjRUXRjAbVccBemMZS1q9AbenM1_-AEjaDlwytUOQwFlKSIB2W5Ag77q9vGZN6fXNUl5JR4BeNsv2SptDVxrgJICp6645C9DTmpMblMCtpowlgCpv8XgL5_ZKOZ24buQcvheijADtraXh6rb-_58-ux2L5-hez8lpBGp8F22sLi7NC_D-VqrjRLyDNtN08GkArweHp8MzONuP-x23owLHEybgOOqlfwFAPGGv |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtMwGLZGdwE3HDYOgQFG4igWramd2EGaUAebOnZQNXXS7kziOLTQJmVphcYV78Bb8BA8DE_Cb8fJliF2t7s0dqK4__ef7P-A0NM4kOBzpYlmpNClqSJuFPvK9cOYyZgrFpoksb39oHdIPxz5Rwvod5ULo8MqK5loBHWSS71HvgaahgY6Q4i8nX51ddcofbpatdCIbGuFZN2UGLOJHTvq5Bu4cMX69nug97NOZ2tz8K7n2i4DrgwYmbmRDGnshSyRnMUkiVIqOfdo2qaR7wVxKBVnknkpSxXYJl5HdTqSAJ_7aeyxBDQAvPcKWqR6A6WFFjc29_sH9TkGA_ujStXhwVoB2kBHGoHL1iaE-i5vqEPTNeBf3XBGOZ4P3Dx3emuU4tZNdN1as7hbwu8WWlDZElruZuDJT07wc2ziS83G_RK60beQwIOyksEy-tWdm_a5-bzAUTKa5oXCM4MEPMo-myCxDOu4ERifjsEqBpC5ILiH-lcxifDL_kH_1Zm5owyDQYvr6Hmcp_hLphTWqSw5cMnQ1HB6gyMMOjrJJ6PvKlnFNl5_rBJsyu3iPz9-2itdxyIHZrmNDi-FrHdQK8szdQ9h6iVeKhOwhGJJqWzHJAI_z5MAb6Lx7CCvoqGQtrK6bvAxFsbD4oEo6S6A7sLQXXAHva6fmZZ1RS6cvaGhUc_UNcHNjfz4k7AiRvhRWzHJgxTYEuwuziUhQcy44lT79YGDXmhgCS254PNkZBMwYJG6Bpjo6jZMYK6FnoNWGjNB4sjmcAVNYSVeIU7500FP6mH9pI7iyxQgCeaUmd-MOuhuieR6SWDYE0pDWCprYLyx5uZINhqaeugM3gt-joNWK244_az__6f3L17FY3S1N9jbFbvb-zsP0LWO4VkflMoKas2O5-oh2KKz-JFleIw-XraM-Qtij540 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZbxMxELagSBUvCFqOhQJGQhyiq8axd-3lLRxROVpFiEp9s9YXCSTeqEkf4In_wL_gZ_FLGHs3S7YcEm-b9TiyM9c38cwYofsq1xBzORMUqUiZszQtVWbTrFBcK2F5EYvEDg7z_SP2-jg7Xqvij9nuqyPJuqYhdGnyy725cbWKi3xvAVY1ZOxA6NOjlGWpOI8uMPDVIanrqD9ozxE4-P9Vqcwf53XcUeza_7ttXnNOZxMnz5yeRqc0vIwuNWgSD2r2X0HnrN9C2wMPkfTsM36AY35n_ON8C20eNMfo2-j74DReWwtRPy7NZF4tLF5GDuCJ_xiTszwO-RowPp8CGgXmpmAwx-HTYlbiR6N3o8drtBOPAUjiNmsdVw5_8tbiUEJSgXSOY--kp7jE4BtNNZt8sWYXN3nyU2twbHOLf3z91jyF_hEVCOlVdDR8-f75ftpc2pDqnNNlWuqCKVJwowVX1JSOaSEIcz1WZiRXhbaCa04cdxagHunbfl9TMJuZU4QbcKjX0IavvL2BMCOGOG0AgSjNmO4pWkJ8RTSIFQ1ylCCy4p3UTUfzcLHGVMbIRuSy5rcEfsvIbykS9KSdM6_7efyT-lkQiZYy9OKOL6qTD7JRbZmVPcu1yB2oA-AdITSlueLCChbi6TxBD4NAyWAxYHm6bAofYJOh95YchOuPACYVJEE7HUrQdN0dXomkbCzNQgICY3monKMJutcOh5khe85bkCSgqSuuOUvQ9VqC2y0BoKaMFbBV3pHtzp67I34yjn3IOXwvxBcJ2l1pwa9l_f03vfl_5HfR5ujFUL59dfjmFrrYj6qbgW3fQRvLk1N7GyDhUt2JWv8Tk8VcCg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Autologous+adipose+tissue+injection+versus+platelet-rich+plasma+%28PRP%29+injection+in+the+treatment+of+knee+osteoarthritis%3A+a+randomized%2C+controlled+study+%E2%80%93+study+protocol&rft.jtitle=BMC+musculoskeletal+disorders&rft.au=B%C4%85kowski%2C+Pawe%C5%82&rft.au=Kaszy%C5%84ski%2C+Jakub&rft.au=Wa%C5%82ecka%2C+Joanna&rft.au=Ciemniewska-Gorzela%2C+Kinga&rft.date=2020-05-20&rft.pub=BioMed+Central&rft.eissn=1471-2474&rft.volume=21&rft.spage=1&rft_id=info:doi/10.1186%2Fs12891-020-03345-8 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2474&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2474&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2474&client=summon |